Ishani Banik, PhD
Postdoctoral Scholar
Radiation Oncology
School of Medicine

Publications (5)

Top publication keywords:
Mitogen-Activated Protein Kinase 14GTP PhosphohydrolasesMutationDNA Copy Number VariationsCell ProliferationMembrane ProteinsApoptosisZebrafishAnisomycinGene Expression Regulation, NeoplasticProtein Kinase InhibitorsSkin NeoplasmsProtein Synthesis InhibitorsTumor Cells, CulturedMelanoma

• The genetic evolution of acral melanoma.
  bioRxiv : the preprint server for biology 2023 Wang M, Fukushima S, Sheen YS, Ramelyte E, Pacheco NC, Shi C, Liu S, Banik I, Aquino JD, Acosta MS, Levesque M, Dummer R, Liau JY, Chu CY, Shain AH, Yeh I, Bastian BC
• P38 Mediates Tumor Suppression through Reduced Autophagy and Actin Cytoskeleton Changes in NRAS-Mutant Melanoma.
  Cancers 2023 Banik I, Ghosh A, Beebe E, Burja B, Bertoncelj MF, Dooley CM, Markkanen E, Dummer R, Busch-Nentwich EM, Levesque MP
• Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes.
  Genome medicine 2022 Wang M, Banik I, Shain AH, Yeh I, Bastian BC
• NRASQ61K melanoma tumor formation is reduced by p38-MAPK14 activation in zebrafish models and NRAS-mutated human melanoma cells.
  Pigment cell & melanoma research 2020 Banik I, Cheng PF, Dooley CM, Travnickova J, Merteroglu M, Dummer R, Patton EE, Busch-Nentwich EM, Levesque MP
• MYSM1/2A-DUB is an epigenetic regulator in human melanoma and contributes to tumor cell growth.
  Oncotarget 2017 Wilms C, Kroeger CM, Hainzl AV, Banik I, Bruno C, Krikki I, Farsam V, Wlaschek M, Gatzka MV